Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tortora

Showing results (11-20 of 180) with videos related to

Pageof 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 5, 2024
To explain the unexplainable in MONARCH 3 overall survival: the restricted mean survival time. Letter to the Editor regarding 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3' by M. P. Goetz et alA Orlandi, L Mastrantoni, E Bria, et al.
La Radiologia Medica|August 4, 1998
[A case of South American blastomycosis of the bones and the lungs]C Pecoraro, A Pinto, G Tortora, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1990
An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effectsG Tortora, T Clair, Y S Cho-Chung
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 7, 2016
Design, development and characterization of a modular end effector for MIS proceduresA Izzo, G Tortora, P Dario, et al.
Current Drug Targets|April 29, 2005
Monoclonal antibodies targeting the epidermal growth factor receptorR Bianco, G Daniele, F Ciardiello, et al.
The International Journal of Biological Markers|May 24, 2007
The rationale for the combination of selective EGFR inhibitors with cytotoxic drugs and radiotherapyG Tortora, T Gelardi, F Ciardiello, et al.
The Journal of Infection|September 10, 2002
Lemierre's disease caused by co-infection of Arcanobacterium haemolyticum and Fusobacterium necrophorum: a case reportF Younus, A Chua, G Tortora, et al.
International Journal of Oncology|May 11, 2011
Biological and clinical relevance of proliferative activity in inflammatory breast-cancerA Paradiso, A Mangia, G Tortora, et al.
Biochemical and Biophysical Research Communications|November 21, 1997
Expression of Wnt5a is downregulated by extracellular matrix and mutated c-Ha-ras in the human mammary epithelial cell line MCF-10AT D Bui, G Tortora, F Ciardiello, et al.
Targeted Oncology|August 15, 2012
Profiling mTOR pathway in neuroendocrine tumorsS Cingarlini, M Bonomi, V Corbo, et al.
Pageof 18

Showing results (11-20 of 180) with videos related to

Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 5, 2024
To explain the unexplainable in MONARCH 3 overall survival: the restricted mean survival time. Letter to the Editor regarding 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3' by M. P. Goetz et alA Orlandi, L Mastrantoni, E Bria, et al.
La Radiologia Medica|August 4, 1998
[A case of South American blastomycosis of the bones and the lungs]C Pecoraro, A Pinto, G Tortora, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1990
An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effectsG Tortora, T Clair, Y S Cho-Chung
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 7, 2016
Design, development and characterization of a modular end effector for MIS proceduresA Izzo, G Tortora, P Dario, et al.
Current Drug Targets|April 29, 2005
Monoclonal antibodies targeting the epidermal growth factor receptorR Bianco, G Daniele, F Ciardiello, et al.
The International Journal of Biological Markers|May 24, 2007
The rationale for the combination of selective EGFR inhibitors with cytotoxic drugs and radiotherapyG Tortora, T Gelardi, F Ciardiello, et al.
The Journal of Infection|September 10, 2002
Lemierre's disease caused by co-infection of Arcanobacterium haemolyticum and Fusobacterium necrophorum: a case reportF Younus, A Chua, G Tortora, et al.
International Journal of Oncology|May 11, 2011
Biological and clinical relevance of proliferative activity in inflammatory breast-cancerA Paradiso, A Mangia, G Tortora, et al.
Biochemical and Biophysical Research Communications|November 21, 1997
Expression of Wnt5a is downregulated by extracellular matrix and mutated c-Ha-ras in the human mammary epithelial cell line MCF-10AT D Bui, G Tortora, F Ciardiello, et al.
Targeted Oncology|August 15, 2012
Profiling mTOR pathway in neuroendocrine tumorsS Cingarlini, M Bonomi, V Corbo, et al.
Pageof 18